Skip to main content
OpenTrials
Completed

NCT Number: NCT02549183

Evaluation of Spinal Cord Stimulation Pulse Rate On Clinical Outcomes

Clinical study to estimate the optimal frequency for stimulation of the spinal cord to achieve relief from back pain.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

North Bristol NHS Trust, Bristol, Avon, United Kingdom

Loading trial locations.

About this study

This is a feasibility study to identify the optimal frequency for stimulation of the spinal cord to achieve maximum reduction in neuropathic back pain as measured by average Numerical rating Scale.

Twenty patients who suffer from back more than leg pain will be recruited into the study once they have satisfactory pain relief from both low and high frequency stimulations. Each patient will then receive stimulation at four different frequencies for 2-3 weeks in a random and blinded order. Their pain scores and function will be assessed using a variety of different tools. The data will then be used to estimate the optimal frequency.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Complaint of persistent or recurrent low back pain, with or without equal or lesser leg pain, for at least 90 days prior to Screen.
  • Received at least 90 days of documented pain management care to address the primary pain complaint, prior to Screening (e.g. medication, physical therapy.)
  • No back surgery within 6 months prior to Screening.
  • Average low back pain intensity, during the position/activity, which routinely causes worst pain, of 5 or greater on a 0-10 numerical rating scale during Baseline period based on eDiary.
  • If taking prescription opioids for primary chronic pain complaint (low back and/or leg pain), must have been on a stable prescription (same drug(s) and dose(s)) 30 days prior to Screening to a total of less than 180 mg Oral Morphine equivalent
  • Willing and able to comply with all protocol-required procedures and assessments/evaluations (e.g. willing to comply with opioid prescription lock from the Baseline visit through End of Rate Randomization and protocol required stimulation parameter locks, complete daily eDiary).
  • 18 years of age or older when written informed consent is obtained.
  • If female of childbearing potential: not pregnant, as evidenced by a negative pregnancy test at Screening.
  • Subject signed a valid, IRB-approved informed consent form (ICF) provided in English.
  • Baseline Oswestry Disability Index score ≥ 20 and ≤ 80.
  • Received at least 30 per cent reduction in NRS of average low back pain intensity from Baseline during the end of Post Implant HF10 Sweet-Spot Search as recorded in the eDiary.

Exclusion criteria

  • Average worst leg pain intensity is greater than average worst low back pain intensity as reported during Baseline period based on eDiary.
  • Radiographic evidence of spinal instability requiring fusion.
  • Primary pain complaint of vascular origin (e.g. peripheral vascular disease).
  • Spinal pain secondary to neoplasm, infection, autoimmune disorder with spinal involvement, or a spinal metabolic disorder.
  • Any pain-related diagnosis or medical/psychological condition that, in the clinician's best judgment might confound reporting of study outcomes (e.g. pelvic pain, angina pain, chronic migraine.
  • Participating (or intends to participate) in another clinical study.
  • Terminal illness with anticipated survival 1 year.
  • Current condition associated with risk of immunocompromised that might increase risk of infection during study duration.
  • Currently on any anticoagulant medications that cannot be discontinued during perioperative period.
  • Are pregnant/lactating or not using adequate birth control.
  • Have untreated major psychiatric comorbidity, serious drug related behaviour issues.

Treatment and study plan

Boston Scientific PRECISION Spinal Cord Stimulator System

Device

Spinal cord stimulation randomly programmed to KHz frequencies; A, B, C and D Kilo Hertz.

Primary outcomes

  1. Back pain relief

    Time frame: Three months

    Mean reported pain on Numerical Rating Scale (NRS)

Secondary outcomes

  1. Leg pain relief

    Time frame: 3-6 months

    Mean reported pain on Numerical Rating Scale (NRS)

  2. Patient global impression of change at end of Long-Term Follow-up

    Time frame: 6-9 months

    Questionnaire

  3. Change in quality of life (EQ-5D) from Baseline Visit to end of Long-Term Follow-up

    Time frame: 6-9 months

    Questionnaire

  4. Change in activities of Daily Living related to back pain disability from Baseline visit to end of Long-Term Follow-up

    Time frame: 6-9 months

    Questionnaire

Sponsors and collaborators

Lead sponsor

Mid and South Essex NHS Foundation Trust

Other

Collaborators

  • North Bristol NHS Trust

Registry information

Official study title

Evaluation of Stimulation Pulse Rate on Clinical Outcomes in Patients Whose Pain is Controlled by 10KHz Frequency - a Feasibility Study

Acronym: PROCO

Important dates

Study start
2015
Primary completion
2017
Study completion
2017
First posted
Sep 15, 2015
Registry last updated
Dec 22, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.